Form 8-K · Current report
Archer Daniels Midland 8-K, filed Nov 3, 2026
- Filed
- CIK
- 0000007084
- Accession no.
- 0000007084-26-000054
Summary
Archer-Daniels-Midland reported third-quarter 2026 net earnings of $821 million, or $1.70 per share, and adjusted EPS of $1.77, and raised its full-year 2026 adjusted EPS guidance to approximately $5.50–$5.80 from a prior range of $5.15–$5.60. The company said the results reflected a constructive biofuels environment and expects year-over-year fourth-quarter operating profit improvement in all segments.
Key points
- Total segment operating profit rose 64% year over year to $1.38 billion in the third quarter of 2026, with adjusted EPS of $1.77.
- ADM lowered its 2026 capital expenditure projection to $1.2–1.3 billion from a prior range of $1.3–1.5 billion.
- Ag Services & Oilseeds operating profit more than doubled to $778 million, Carbohydrate Solutions rose 40% to $470 million and Nutrition rose 3% to $134 million.
- Chair and CEO Juan Luciano attributed the results to a constructive biofuels environment, ADM's North American footprint and execution by its team.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02Results of Operations and Financial Condition. On November 3, 2026, Archer-Daniels-Midland Company (ADM) issued a press release announcing third quarter results. A copy of such press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.